AKT2 and cancer: Proteins such as AKT2, KIT, ABL1, KDR, AKT1, IGF1, EGFR, FGFR1 and IGF1R which play key roles in Ras signaling pathway are direct targets of Tamarixetin indicating the anti-cancer potential of Tamarixetin.